Efficacy and safety of pneumatic trabeculoplasty versus timolol added to latanoprost in primary open angle glaucoma

dc.authorid0000-0001-5335-3860
dc.authorid0000-0001-8954-5055
dc.contributor.authorKocabora, Mehmet Selim
dc.contributor.authorÖzsütçü, Mustafa
dc.contributor.authorKandemir, Nilay
dc.contributor.authorGöçmez, Erhan
dc.contributor.authorFazıl, Korhan
dc.contributor.authorGülkılık, Gökhan
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:51:10Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:51:10Z
dc.date.issued2013
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Göz Hastalıkları Ana Bilim Dalı
dc.descriptionWOS: 000325617700003
dc.descriptionPubMed ID: 24045520
dc.description.abstractBackground. To compare the safety and short-term additive hypotensive effect of pneumatic trabeculoplasty (PNT) versus timolol among patients receiving topical latanoprost for primary open angle glaucoma (POAG). Patients and Methods. This study prospectively evaluated 30 eyes of 30 patients with POAG receiving latanoprost monotherapy. We randomly assigned 15 eyes to PNT plus latanoprost (Group A), and 15 eyes to latanoprost/ timolol fixed combination therapy (Group B). PNT treatment was performed at days 0, 7, and 90. Follow-up visits occurred at day 1, week 1, and months 1 and 3. Results. Compared to baseline values, both treatments significantly lowered IOP (p <= 0.001). The mean IOP for Group A was 21.13 +/- 1.6 mmHg at baseline and 18.7 +/- 1.5 mmHg at three months (p <= 0.001). For Group B, mean IOP was 20.8 +/- 1.9 mmHg at baseline and 18.9 +/- 0.8 mmHg at three months (p <= 0.001). Transient conjunctival hyperaemia, the only adverse effect occurring after PNT, was observed in all patients in Group A. Conclusion. The additive IOP-lowering effect of PNT was similar to timolol in patients with POAG receiving latanoprost.
dc.identifier.citationKocabora, M. S., Özsütçü, M., Kandemir, N., Göçmez, E., Fazıl, K. ve Gülkılık, G. (2013). Efficacy and safety of pneumatic trabeculoplasty versus timolol added to latanoprost in primary open angle glaucoma. Clinica Terapeutica, 164(4), E259-E262. https://dx.doi.org/10.7417/CT.2013.1585
dc.identifier.doi10.7417/CT.2013.1585
dc.identifier.endpageE262
dc.identifier.issn0009-9074
dc.identifier.issn1972-6007
dc.identifier.issue4
dc.identifier.scopusqualityQ3
dc.identifier.startpageE259
dc.identifier.urihttps://dx.doi.org/10.7417/CT.2013.1585
dc.identifier.urihttps://hdl.handle.net/20.500.12511/2161
dc.identifier.volume164
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSoc Editrice Univ
dc.relation.ispartofClinica Terapeuticaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectGlaucoma
dc.subjectIntraocular Pressure
dc.subjectlatanoprost
dc.subjectPneumatic Trabeculoplasty
dc.subjectTimolol
dc.titleEfficacy and safety of pneumatic trabeculoplasty versus timolol added to latanoprost in primary open angle glaucoma
dc.typeArticle

Dosyalar